<SEC-DOCUMENT>0001558370-20-004176-index.html : 20200423
<SEC-HEADER>0001558370-20-004176.hdr.sgml : 20200423
<ACCEPTANCE-DATETIME>20200423070123
ACCESSION NUMBER:		0001558370-20-004176
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20200604
FILED AS OF DATE:		20200423
DATE AS OF CHANGE:		20200423
EFFECTIVENESS DATE:		20200423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aclaris Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001557746
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				460571712
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37581
		FILM NUMBER:		20809162

	BUSINESS ADDRESS:	
		STREET 1:		640 LEE ROAD
		STREET 2:		SUITE 200
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
		BUSINESS PHONE:		484-324-7933

	MAIL ADDRESS:	
		STREET 1:		640 LEE ROAD
		STREET 2:		SUITE 200
		CITY:			WAYNE
		STATE:			PA
		ZIP:			19087
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tmb-20200604xdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: tmb-20200604xdef14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tmb-20200604xdef14a001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: tmb-20200604xdef14a001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tmb-20200604xdef14a010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: tmb-20200604xdef14a010.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tmb-20200604xdef14a011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tmb-20200604xdef14a011.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tmb-20200604xdef14a009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: tmb-20200604xdef14a009.jpg

</DOCUMENT>
</SEC-DOCUMENT>